Results

eNauka >  Results >  Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Title: Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Authors Colombel, Jean Frederic; ...; Sreckovic, Slobodan; ...; (broj, koautora 33)
Issue Date: 2025
Publication: JOURNAL OF CROHNS & COLITIS
ISSN: 1873-9946 Journal of Crohn#s and Colitis Search Idenfier
Type: Article
Collation: vol. 19 br. 6
DOI: 10.1093/ecco-jcc/jjaf060
WoS-ID: 001501381900001
Scopus-ID: 2-s2.0-105008338734
PMID: 40243842
PMCID: PMC12134888
URI: https://enauka.gov.rs/handle/123456789/984910
Project: Celltrion, Inc
Celltrion, Inc. (Incheon, Republic of Korea)
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

2
SCOPUSTM
4
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.